LIVERO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,410 JPY | -4.02% |
|
-4.08% | +37.43% |
| 2023 | Livero Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2023 | Tranche Update on Livero Inc.'s Equity Buyback Plan announced on February 20, 2023. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 40.36 and 22.57 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Real Estate Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +37.43% | 48.82M | - | ||
| -5.39% | 26.56B | B+ | ||
| +4.75% | 20.64B | C- | ||
| -15.51% | 9.93B | B- | ||
| -29.20% | 9.62B | C- | ||
| +6.99% | 9.61B | B+ | ||
| -6.78% | 6.6B | C- | ||
| -8.81% | 5.63B | B+ | ||
| +32.03% | 4.21B | - | - | |
| +2.87% | 2.55B | C+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 9245 Stock
- Ratings Livero Inc.
